Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer
Abstract Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC), less evidence is available for its significance in neoadjuvant chemotherapy (NCT) in early breast cancer (BC). Here we conducted an analysis of...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2876 |
id |
doaj-d0be2544a72f455abac3a060ccbca3ea |
---|---|
record_format |
Article |
spelling |
doaj-d0be2544a72f455abac3a060ccbca3ea2020-11-25T02:39:04ZengWileyCancer Medicine2045-76342020-04-01972290229810.1002/cam4.2876Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancerChao Ni0Yimin Shen1Qingqing Fang2Min Zhang3Hongjun Yuan4Jingxia Zhang5Miaochun Zhong6Yajuan Zheng7Department of Breast Surgery (Surgical Oncology) The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Endocrinology The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Huzhou Central Hospital Zhejiang University Huzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaDepartment of Breast Surgery Zhejiang Provincial People's Hospital People's Hospital of Hangzhou Medical College Hangzhou Zhejiang ChinaAbstract Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC), less evidence is available for its significance in neoadjuvant chemotherapy (NCT) in early breast cancer (BC). Here we conducted an analysis of individual data from 86 patients confirmed as invasive BC by core‐needle biopsy in Zhejiang Provincial People's Hospital between June 2013 and January 2017. The CTCs were assessed at the time after diagnosis and before surgery with the CanPatrol technique. The median follow‐up duration was 46.3 months. CTCs were detected in 37.2% of all patients (29/78) at baseline, and the presence of CTCs was associated with tumor size, tumor stage, and molecular classification. After NCT, the CTC‐positive patients were dropped from 29 to 8, and the EC‐T (epirubicin/cyclophosphamide followed by docetaxel) and TEC (docetaxel/epirubicin/cyclophosphamide) strategies reduce CTC‐positive patients from 16 to 3 and 13 to 5, respectively. The CTC‐negative conversion rates were similar in ER/PR+ HER2+ (5/7, 71.4%), ER/PR− HER2+ (8/11, 72.7%), and TNBC (7/10, 70%) during NCT. In addition, we explored the association between CTC‐negative conversion and objective response rate (partial response and complete response, ORR) and pathological complete response rate (pCR), and our results indicate that ORR was higher in patients with positive CTCs and converted to negative after NCT (ORR, P = .013; pCR, P = .0608). Our study preliminarily highlights the relevance of CTC status and NCT effectiveness in early BC using the CanPatrol system.https://doi.org/10.1002/cam4.2876CanPatrol systemCTCsearly breast cancerneoadjuvant chemotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chao Ni Yimin Shen Qingqing Fang Min Zhang Hongjun Yuan Jingxia Zhang Miaochun Zhong Yajuan Zheng |
spellingShingle |
Chao Ni Yimin Shen Qingqing Fang Min Zhang Hongjun Yuan Jingxia Zhang Miaochun Zhong Yajuan Zheng Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer Cancer Medicine CanPatrol system CTCs early breast cancer neoadjuvant chemotherapy |
author_facet |
Chao Ni Yimin Shen Qingqing Fang Min Zhang Hongjun Yuan Jingxia Zhang Miaochun Zhong Yajuan Zheng |
author_sort |
Chao Ni |
title |
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer |
title_short |
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer |
title_full |
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer |
title_fullStr |
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer |
title_full_unstemmed |
Prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer |
title_sort |
prospective study of the relevance of circulating tumor cell status and neoadjuvant chemotherapy effectiveness in early breast cancer |
publisher |
Wiley |
series |
Cancer Medicine |
issn |
2045-7634 |
publishDate |
2020-04-01 |
description |
Abstract Although unequivocal evidence has shown the prognostic relevance of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC), less evidence is available for its significance in neoadjuvant chemotherapy (NCT) in early breast cancer (BC). Here we conducted an analysis of individual data from 86 patients confirmed as invasive BC by core‐needle biopsy in Zhejiang Provincial People's Hospital between June 2013 and January 2017. The CTCs were assessed at the time after diagnosis and before surgery with the CanPatrol technique. The median follow‐up duration was 46.3 months. CTCs were detected in 37.2% of all patients (29/78) at baseline, and the presence of CTCs was associated with tumor size, tumor stage, and molecular classification. After NCT, the CTC‐positive patients were dropped from 29 to 8, and the EC‐T (epirubicin/cyclophosphamide followed by docetaxel) and TEC (docetaxel/epirubicin/cyclophosphamide) strategies reduce CTC‐positive patients from 16 to 3 and 13 to 5, respectively. The CTC‐negative conversion rates were similar in ER/PR+ HER2+ (5/7, 71.4%), ER/PR− HER2+ (8/11, 72.7%), and TNBC (7/10, 70%) during NCT. In addition, we explored the association between CTC‐negative conversion and objective response rate (partial response and complete response, ORR) and pathological complete response rate (pCR), and our results indicate that ORR was higher in patients with positive CTCs and converted to negative after NCT (ORR, P = .013; pCR, P = .0608). Our study preliminarily highlights the relevance of CTC status and NCT effectiveness in early BC using the CanPatrol system. |
topic |
CanPatrol system CTCs early breast cancer neoadjuvant chemotherapy |
url |
https://doi.org/10.1002/cam4.2876 |
work_keys_str_mv |
AT chaoni prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT yiminshen prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT qingqingfang prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT minzhang prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT hongjunyuan prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT jingxiazhang prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT miaochunzhong prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer AT yajuanzheng prospectivestudyoftherelevanceofcirculatingtumorcellstatusandneoadjuvantchemotherapyeffectivenessinearlybreastcancer |
_version_ |
1724787812953227264 |